Suppr超能文献

韩国骨肉瘤和软组织肉瘤的人口统计学、治疗模式变化及治疗结果——一项基于肉瘤特异性机构登记处的分析

Demographics, Changes in Treatment Patterns, and Outcomes of Bone and Soft Tissue Sarcomas in Korea-A Sarcoma-Specific, Institutional Registry-Based Analysis.

作者信息

Jeong Hyehyun, Im Hyeon-Su, Kim Wanlim, Lee Jong-Seok, Song Si Yeol, Song Joon Seon, Cho Kyung-Ja, Chung Hye Won, Lee Min Hee, Kim Jeong Eun, Ahn Jin-Hee

机构信息

Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.

Division of Hematology and Oncology, Ulsan University Hospital, Ulsan, Republic of Korea.

出版信息

Cancer Manag Res. 2021 Nov 24;13:8795-8802. doi: 10.2147/CMAR.S337606. eCollection 2021.

Abstract

PURPOSE

Because of the heterogeneity of sarcomas, establishing a well-collected, sarcoma-specific database is important for sarcoma research. We analyzed the first histology-based, sarcoma-specific institutional registry in Korea, which collected 28 years of patient data according to a predefined data format.

PATIENTS AND METHODS

Adult bone and soft tissue sarcoma patients who were treated from June 1989 to January 2017 were identified and analyzed, based on the ICD-O-3 codes.

RESULTS

Among the 3420 patients included, soft tissue and bone sarcomas comprised 77.8% (n = 2661) and 22.2% (n = 759), respectively. Median age at diagnosis was 50 (range, 16-98) in soft tissue sarcomas and 37 (range, 16-85) in bone sarcomas. Males and females comprised 45.5% and 54.5% of soft tissue sarcomas and 52.7% and 47.3% of bone sarcomas, respectively. Among the 3407 patients with treatment data available, 90.5% of the patients with soft tissue sarcomas and 80.8% of the patients with bone sarcomas received surgery first, of which 57.8% and 71.7% did not receive any subsequent treatment, respectively. Overall, the proportion of patients who received surgery alone decreased from 85.7% to 60.5% from the pre-2000 period to the 2010-2017 period. However, the use of adjuvant chemotherapy increased in patients with soft tissue sarcomas (from 8.0% to 17.2% in the same period), and the use of perioperative radiotherapy also increased in both groups (from 1.4% to 22.7% in soft tissue sarcomas, and 0% to 14.5% in bone sarcomas in the same period). In both soft tissue and bone sarcomas, old age (≥65 years) and diagnosis in the early study period were associated with poorer survival.

CONCLUSION

We presented a comprehensive summary of our sarcoma registry, including the demographics, changes in treatment patterns, and survival outcomes. This study will provide a framework for future studies.

摘要

目的

由于肉瘤具有异质性,建立一个收集完善的、肉瘤特异性数据库对于肉瘤研究至关重要。我们分析了韩国首个基于组织学的、肉瘤特异性机构登记处的数据,该登记处按照预定义的数据格式收集了28年的患者数据。

患者与方法

根据ICD-O-3编码,确定并分析了1989年6月至2017年1月期间接受治疗的成人骨肉瘤和软组织肉瘤患者。

结果

在纳入的3420例患者中,软组织肉瘤和骨肉瘤分别占77.8%(n = 2661)和22.2%(n = 759)。软组织肉瘤诊断时的中位年龄为50岁(范围16 - 98岁),骨肉瘤为37岁(范围16 - 85岁)。软组织肉瘤中男性和女性分别占45.5%和54.5%,骨肉瘤中分别占52.7%和47.3%。在有治疗数据的3407例患者中,90.5%的软组织肉瘤患者和80.8%的骨肉瘤患者首先接受了手术,其中分别有57.8%和71.7%未接受任何后续治疗。总体而言,单纯接受手术的患者比例从2000年前的85.7%降至2010 - 2017年期间的60.5%。然而,软组织肉瘤患者辅助化疗的使用有所增加(同期从8.0%增至17.2%),两组围手术期放疗的使用也均增加(软组织肉瘤同期从1.4%增至22.7%,骨肉瘤从0%增至14.5%)。在软组织肉瘤和骨肉瘤中,老年(≥65岁)以及在研究早期诊断均与较差的生存率相关。

结论

我们展示了肉瘤登记处的全面总结,包括人口统计学、治疗模式变化和生存结果。本研究将为未来研究提供一个框架。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验